FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, namely to oncology, and can be used for treatment of cerebral glioma. For this purpose combination of cannabinoids-tetrahydrocannabinol (THC) and cannabidiol (CBD) and non-cannabinoid chemotherapeutic agent is claimed. THC and CBD ratio constitutes from 5:1 to 1:5.
EFFECT: combination of anti-tumour medications provides efficient reduction of brain tumour volume due to selective death of transformed cells.
14 cl, 2 tbl, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-TUMOUR EFFECTS OF COMBINATIONS OF CANNABIS COMPOUNDS | 2009 |
|
RU2546284C2 |
| CANNABINOID DRUGS | 2001 |
|
RU2273476C2 |
| ONCOLYTIC HERPES SIMPLEX VIRUSES TYPE 1 FOR TREATING BRAIN TUMOURS | 2021 |
|
RU2824514C1 |
| DEOXYDERIVATIVES OF CYTIDINE OR URIDINE FOR USE IN THE TREATMENT OF CANCER | 2020 |
|
RU2797489C2 |
| METHOD FOR TREATING ENDOMETRIOSIS WITH PAIN SYNDROME AND PHARMACEUTICAL COMPOSITION FOR ITS IMPLEMENTATION | 2020 |
|
RU2745687C1 |
| CEREBRAL CANCER TREATMENT WITH ONCOLYTIC ADENOVIRUS | 2014 |
|
RU2689553C2 |
| COMBINATION THERAPY WITH ANTITUMOR ALKALOID | 2018 |
|
RU2757373C2 |
| METHODS OF TREATING CANCER DISEASES AND TUMORS USING PDE1 INHIBITORS | 2019 |
|
RU2811918C2 |
| METHOD FOR DECREASING CELL PROLIFERATION BASED UPON (3R,4R)- ▵8-TETRAHYDROCANNABINOL-11-ONIC ACIDS (HEMP-OBTAINED ACIDS) | 2001 |
|
RU2272620C2 |
| COMBINATION THERAPY WITH ANTITUMOR ALKALOID | 2011 |
|
RU2743643C2 |
